OxyNov Inc.
PrivateLast Round
Grant
Feb 2, 2021
Total Funding Raised
$180,000
Company Overview
OxyNov Inc. operates in Healthcare & Life Sciences and is based in Canada. Its latest recorded funding round was a Grant round in February 2021.
OxyNov Inc. is a medical device company that develops and commercializes automated oxygen therapy systems, including its flagship FreeO₂ device, to optimize respiratory care and improve patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OxyNov Inc. Comparables
Compare OxyNov Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| O2matic ApS | 89% | |
| Danaher Corporation | 78% | |
| Vapotherm | 76% |
For institutional investors. Book with your work email.
OxyNov Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2021 | ||||
| Series A | Oct 17, 2018 | ||||
| VC Round | Mar 15, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OxyNov Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Desjardins Capital | VC Round, Series A |
| Anges Quebec | VC Round |
| Ville de Québec | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2021
$180K grant received from Ville de Québec
- Oct 17, 2018
Led by Vygon with participation from Desjardins Capital.
For institutional investors. Book with your work email.
OxyNov Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OxyNov Inc.'s valuation, stock price, and market status.
Is OxyNov Inc. a public or private company?
OxyNov Inc. is a private company.
What is the current stock price of OxyNov Inc.?
OxyNov Inc. is a private company, so its shares have no public market price. Caplight tracks OxyNov Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OxyNov Inc. worth (valuation)?
Valuation information for OxyNov Inc. is not publicly available.
Can I buy OxyNov Inc. stock?
OxyNov Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OxyNov Inc.'s last funding round?
OxyNov Inc.'s most recent funding round was Grant on February 2, 2021.
Who are the main investors in OxyNov Inc.?
Key investors in OxyNov Inc. include Desjardins Capital, Anges Quebec, Ville de Québec.
Will OxyNov Inc. IPO soon?
No public IPO plans have been announced for OxyNov Inc..
How can I track OxyNov Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OxyNov Inc.'s shares on secondary markets.